Acute coronary syndrome: new advances and nursing strategies.
Glycoprotein IIb/IIIa receptor inhibitors are the newest therapy for acute coronary syndrome (ACS). This article reviews the pathophysiology of ACS, the role of glycoprotein IIb/IIIa receptor inhibitors, and nursing care for patients undergoing this therapy and coronary interventions.
Palatnik
A M
AM
Our Lady of Lourdes Medical Center, Camden, N.J., USA.
D000208:Acute Disease; D000789:Angina, Unstable / Q000451:nursing / Q000503:physiopathology / Q000628:therapy; D000800:Angioplasty, Balloon; D017073:Atherectomy; D003131:Combined Modality Therapy; D003327:Coronary Disease / Q000451:nursing* / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D009203:Myocardial Infarction / Q000451:nursing / Q000503:physiopathology / Q000628:therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D015607:Stents; D013577:Syndrome; D014654:Vascular Patency / Q000187:drug effects
D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex